Bayerpaul Pharmaceutical Group Pharmaceutical Group has been granted a GMP-based operating license by the Food and Drug Administration for the production of human vaccines and is currently manufacturing two types of egg‑based human influenza vaccines.
| ®Flopak | Seasonal Influenza vaccine (Trivalent) |
| ®Flopak | Seasonal Influenza vaccine (Quadrivalent) |
Seasonal Trivalent Influenza Vaccine Flopak®
The first vaccine produced on the production line of Bayerpl PharmaTech is the influenza vaccine (FluPak). The vaccine is manufactured in compliance with GMP standards, WHO requirements, and regulations set by the Ministry of Health’s Food and Drug Administration. The FluPak vaccine is produced by cultivating the virus on eggs and formulated without the use of thiomersal preservatives. It is available in pre-filled syringes in a volume of half a milliliter since 2018.
Seasonal Quadrivalent Influenza Vaacine Flopak®
The vaccine is manufactured in compliance with GMP standards, WHO requirements, and regulations set by the Ministry of Health’s Food and Drug Administration. The FluPak vaccine is produced by cultivating the virus on eggs and formulated without the use of thiomersal preservatives. It is available in pre-filled syringes in a volume of half a milliliter since 2018.